Cargando…
Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
BACKGROUND: The existence of cancer stem cells (CSCs) or cancer stem-like cells in a tumor mass is believed to be responsible for tumor recurrence because of their intrinsic and extrinsic drug-resistance characteristics. Therefore, targeted killing of CSCs would be a newer strategy for the preventio...
Autores principales: | Bao, Bin, Ali, Shadan, Kong, Dejuan, Sarkar, Sanila H., Wang, Zhiwei, Banerjee, Sanjeev, Aboukameel, Amro, Padhye, Subhash, Philip, Philip A., Sarkar, Fazlul H. |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2011
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3052388/ https://www.ncbi.nlm.nih.gov/pubmed/21408027 http://dx.doi.org/10.1371/journal.pone.0017850 |
Ejemplares similares
-
Hypoxia-Induced Aggressiveness of Pancreatic Cancer Cells Is Due to Increased Expression of VEGF, IL-6 and miR-21, Which Can Be Attenuated by CDF Treatment
por: Bao, Bin, et al.
Publicado: (2012) -
Difluorinated-Curcumin (CDF) Restores PTEN Expression in Colon Cancer Cells by Down-Regulating miR-21
por: Roy, Sanchita, et al.
Publicado: (2013) -
Hypoxia Induced Aggressiveness of Prostate Cancer Cells Is Linked with Deregulated Expression of VEGF, IL-6 and miRNAs That Are Attenuated by CDF
por: Bao, Bin, et al.
Publicado: (2012) -
Retraction: Anti-Tumor Activity of a Novel Compound-CDF Is Mediated by Regulating miR-21, miR-200, and PTEN in Pancreatic Cancer
Publicado: (2018) -
Expression of miR-34 is lost in colon cancer which can be re-expressed by a novel agent CDF
por: Roy, Sanchita, et al.
Publicado: (2012)